Independent Pharmacy Cooperative (IPC) and McKesson Forge New Supply Agreement

SUN PRAIRIE, Wis., June 24, 2024 /PRNewswire/ — Independent Pharmacy Cooperative (IPC), a leading group purchasing organization of community pharmacies, is pleased to announce a new supply agreement with McKesson, a diversified healthcare leader and pharmaceutical distribution wholesaler. The agreement, meticulously negotiated over the past year, marks a significant milestone in our commitment to empowering our member pharmacies.

This new supply agreement provides IPC members with two distinct pricing options, allowing them to tailor their approach to better serve their communities and thrive in a competitive market. These options will be presented to member pharmacies over the next month, with an effective date of August 1st, 2024.

In a statement, IPC CEO Marc Essensa emphasized the strategic significance of this agreement for our community pharmacy network:
“Our collaboration with McKesson reflects our unwavering commitment to our members’ success. By offering these pathways, we empower pharmacies to make informed decisions that align with their unique business models. This agreement underscores our dedication to fostering choice, innovation, and resilience within the independent pharmacy landscape. Through the agreement, McKesson and IPC worked together to help support IPC members’ access to the digital health platform.”

About Independent Pharmacy Cooperative (IPC)
IPC, founded in 1983, is a member-owned cooperative that champions the interests of independent pharmacies across the United States. Our mission is to provide resources, advocacy, and collaborative opportunities that strengthen community pharmacy practices.

View original content to download multimedia:https://www.prnewswire.com/news-releases/independent-pharmacy-cooperative-ipc-and-mckesson-forge-new-supply-agreement-302180799.html

SOURCE IPC (Independent Pharmacy Cooperative)

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

26 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

26 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago